Azacitidine shows promising effectiveness and favorable glucocorticoid-sparing effects in patients with genetically confirmed ...

Lenalidomide with rituximab (R 2) is already a common, chemotherapy-free option for FL in the first, and especially second, lines. Adding tafasitamab, an anti-CD19 immunotherapy, improved ...

When antihistamines and steroids fall short, doctors should consider the hidden neuropathic cause of stubborn summer itching.

Compulsive or addictive patterns of screen use — rather than total time spent on devices — may pose a greater risk to adolescents’ mental health, new research shows.

From full-sugar sodas to smoothies and booze, hidden calories and sugars are easy to pile up. Here’s how to warn your ...

Compared with other systemic agents for treating atopic dermatitis, dupilumab is associated with an increased risk for ...

All intermittent fasting and calorie restriction diets reduce body weight similarly compared but alternate-day fasting yields ...

Dr Teresa Amaral poses a treatment question for a hypothetical patient after sharing information on biomarkers and adjuvant therapy in previous discussions.

Many patients with systemic sclerosis presented without the warning sign of Raynaud phenomenon as their initial symptom in an ...

Pre-workout supplements may promise results, but experts warn they can lead to arrhythmias, hospitalizations, and even death ...

Health policy experts say the tariffs would raise prices for patients, potentially disrupt supply, and could hurt the US ...

At ASCO 2025, an expert discusses encouraging new early-phase research in clinical trials on treating myeloma.